PRINCETON, N.J.-- Bristol-Myers Squibb Company (NYSE:BMY) today announced important next steps in the evolution of the company’s R&D organization, including plans to expand its presence within hubs of scientific excellence and innovation with the opening of a new state-of-the-art research site in Cambridge, Mass. in addition to the ongoing expansion of the company’s R&D Discovery site […]
Thank you for your interest in The Registry. If you'd like to read further, you must Subscribe or Log In below to read the rest of this content.
Signup for news and special announcements!
You have successfully joined our subscriber list.
A national gathering of CEOs, Leaders, and Executives in an invitation-only room...
BypublisherxSeptember 24, 2026Sponsors anticipate another sell-out for popular charity ride in Sonoma County countryside
ByThe RegistrySeptember 21, 2026Marcus & Millichap arranged the $5.75M Sale and $3.8M financing of the...
ByThe RegistryAugust 22, 2026Leading independent triple net lease (NNN) platform across North America and Europe...
ByThe RegistryAugust 18, 2026